Literature DB >> 22874365

Developing a patient education method - the e-Knowledge Test with feedback.

Mervi Siekkinen1, Helena Leino-Kilpi.   

Abstract

Breast cancer and its treatment radiotherapy, have impact on woman's psychosocial and physical well-being causing disruption to quality of life. Because of the positive effects of knowledge on quality of life there is a challenge to develop effective education methods. Due to the growing use of internet among breast cancer patients the development should be focused on e-education. An e-education method, the e-Knowledge Test of radiotherapy with feedback for breast cancer patients (e-KTRT-BC) was planned and piloted. The content of it based on literature of breast cancer patients' knowledge needs of radiotherapy and structured through aspects of empowerment as a nursing intervention. The face validity study that was conducted via email revealed that the content of e-KTRC-BC was easy to use and understand. The e-KTRT-BC could be used as an e-education method to meet the breast cancer patients' knowledge needs. Evaluating the empowering effect of patient e-education with feedback is important for further development of e-education methods.

Entities:  

Mesh:

Year:  2012        PMID: 22874365

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  2 in total

1.  Instruments for Patient Education: Psychometric Evaluation of the Expected Knowledge (EKhp) and the Received Knowledge of Hospital Patients (RKhp).

Authors:  Helena Leino-Kilpi; Saija Inkeroinen; Esther Cabrera; Andreas Charalambous; Natalja Fatkulina; Jouko Katajisto; Árún K Sigurðardóttir; Panayota Sourtzi; Riitta Suhonen; Adelaida Zabalegui; Kirsi Valkeapää
Journal:  J Multidiscip Healthc       Date:  2020-11-10

2.  Breast Cancer Patients' Perceptions of a Virtual Learning Environment for Pretreatment Education.

Authors:  Yobelli Alexandra Jimenez; Wei Wang; Kirsty Stuart; Steven Cumming; David Thwaites; Sarah Lewis
Journal:  J Cancer Educ       Date:  2018-10       Impact factor: 2.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.